TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Centers for Disease Control and Prevention (U.S.)
KW - Chronic Pain/drug therapy
KW - Drug and Narcotic Control/legislation & jurisprudence
KW - Health Policy
KW - Humans
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy/epidemiology/prevention & control
KW - Practice Guidelines as Topic
KW - Practice Patterns, Physicians'/legislation & jurisprudence
KW - Rhode Island/epidemiology
KW - United States/epidemiology
KW - Analgesics
KW - buprenorphine
KW - Chronic Pain
KW - formal
KW - Opioid
KW - Referral and Consultation
KW - social control
AU - A. L. Gordon
AU - A. F. Snyder
A1 - 
AB - New Rhode Island regulations require physicians and other licensed practitioners to make significant adjustments to comply with new requirements for prescribing narcotics for chronic pain. Responding to the opioid epidemic, the new rules are intended to improve patient safety by changing physicians' prescribing patterns. However, the new rules may overlook the importance of treatment-access problems and the importance of buprenorphine products for treating pain and opioid dependence. Empirical data have demonstrated the safety and efficacy of buprenorphine in treating opioid-dependent patients with chronic pain, including those with and without substance abuse histories, but access to buprenorphine treatment remains limited throughout the state. The new regulations call upon physicians to make use of consultation services, which are also of limited availability. Although well intentioned, the new rules may contribute to treatment-access problems, and patients with chronic pain may resort to higher-risk "street" drugs when they are unable to access safe but effective medical treatment. [Full article available at http://rimed.org/rimedicaljournal-2017-10.asp].
AD - Chief of Clinical Addiction Services, Butler Hospital; Clinical Associate Professor of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI.; Butler Hospital, Providence, RI.
BT - Rhode Island medical journal (2013)
C5 - Opioids & Substance Use
CP - 10
CY - United States
IS - 10
JF - Rhode Island medical journal (2013)
M1 - Journal Article
N2 - New Rhode Island regulations require physicians and other licensed practitioners to make significant adjustments to comply with new requirements for prescribing narcotics for chronic pain. Responding to the opioid epidemic, the new rules are intended to improve patient safety by changing physicians' prescribing patterns. However, the new rules may overlook the importance of treatment-access problems and the importance of buprenorphine products for treating pain and opioid dependence. Empirical data have demonstrated the safety and efficacy of buprenorphine in treating opioid-dependent patients with chronic pain, including those with and without substance abuse histories, but access to buprenorphine treatment remains limited throughout the state. The new regulations call upon physicians to make use of consultation services, which are also of limited availability. Although well intentioned, the new rules may contribute to treatment-access problems, and patients with chronic pain may resort to higher-risk "street" drugs when they are unable to access safe but effective medical treatment. [Full article available at http://rimed.org/rimedicaljournal-2017-10.asp].
PP - United States
PY - 2017
SN - 2327-2228; 0363-7913
SP - 45
EP - 47
EP - 
T1 - Responsible Opioid Prescribing for Chronic Pain: Interpreting the CDC Guideline, Understanding New Rhode Island Regulations
T2 - Rhode Island medical journal (2013)
TI - Responsible Opioid Prescribing for Chronic Pain: Interpreting the CDC Guideline, Understanding New Rhode Island Regulations
U1 - Opioids & Substance Use
U2 - 28968623
VL - 100
VO - 2327-2228; 0363-7913
Y1 - 2017
Y2 - Oct 2
ER -